12 01 2010 chemoinformatics DMPK Tweet
新しい本が出るらしい。
Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology (Wiley Series in Drug Discovery and Development)
Wiley / ¥ 9,585 ()
近日発売 予約可
Wiley / ¥ 9,585 ()
近日発売 予約可
- Cover drug transporters, cytochrome P-450 and drug-drug interactions, plasma protein binding, stability, drug formulation, preclinical safety assessment, toxicology, and toxicokinetics
- Address developability issues that challenge pharma companies, moving beyond isolated experimental results
- Reveal connections between the key scientific areas that are critical for successful drug discovery and development
- Inspire forward-thinking strategies and decision-making processes in preclinical evaluation to maximize the potential of drug candidates to progress through development efficiently and meet the increasing demands of the marketplace
Evaluation of Drug Candidates for Preclinical Development serves as an introductory reference for those new to the pharmaceutical industry and drug discovery in particular. It is especially well suited for scientists and management teams in small- to mid-sized pharmaceutical companies, as well as academic researchers and graduate students concerned with the practical aspects related to the evaluation of drug developability.